Jobe, Ousman
Kim, Jiae
Pinto, Daniel O.
Villar, Zuzana
Hewitt, Tiffany
Duncan, Elizabeth H.
Anderson, Alexander
Gohain, Neelakshi
Gong, Hua
Tucker, Courtney
Alving, Carl R.
Matyas, Gary R.
Bergmann-Leitner, Elke
Rao, Mangala
Article History
Received: 12 October 2021
Accepted: 18 April 2022
First Online: 9 May 2022
Competing interests
: C.R.A is a co-inventor on U.S. patent 10,434,167 entitled “Non-toxic adjuvant formulation comprising a monophosphoryl lipid A (MPLA)-containing liposome composition and a saponin.” G.R.M and C.R.A. are named co-inventors on “Compositions And Methods For Vaccine Delivery”, US Patent Application: 16/607,917. The other authors declare that there are no competing interests.